Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends European approval of once-weekly somatropin

June 3, 2013

CMDh endorses EMA committee's recommendation on benefit/risk profile of Diane-35

June 3, 2013

European CHMP recommends approval of Lojuxta

June 3, 2013

European CHMP recommends approval of pomalidomide for rrMM

June 3, 2013

BioMarin's applications for Vimizim accepted by both FDA and EMA

May 31, 2013

EMA grants orphan drug designation to Sucampo's retinitis pigmentosa therapeutic

May 30, 2013

EMA grants accelerated assessment to Gilead's MAA for sofosbuvir

May 22, 2013

EMA's CHMP recommends restricting use of Protelos/Osseor

April 29, 2013

European CHMP recommends conditional approval of Erivedge for BCC

April 29, 2013

CHMP issues positive opinion for approval of Nuedexta

April 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...